Stock CGON CG ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. CG Oncology, Inc.

Equities

CGON

US1569441009

Real-time Estimate Cboe BZX
Other stock markets
 09:53:58 2024-05-23 am EDT 		5-day change 1st Jan Change
30.76 USD -0.16% Intraday chart for CG Oncology, Inc. -1.04% 0.00%
May. 14 Goldman Sachs Upgrades CG Oncology to Buy From Neutral With $50 Price Target MT
May. 09 CG Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Goldman Sachs Upgrades CG Oncology to Buy From Neutral With $50 Price Target
MT
Cantor Fitzgerald Starts Coverage on CG Oncology With Overweight Rating, $75 Price Target
MT
Goldman Sachs Initiates Coverage on CG Oncology With Neutral Rating, $42 Price Target
MT
Morgan Stanley Initiates CG Oncology With Overweight Rating, Price Target is $55
MT
HC Wainwright Starts Coverage on CG Oncology With Buy Rating, $75 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CGON Stock
  4. News CG Oncology, Inc.
  5. Analyst Reco.